B
Baird Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
626
Mastercard
MA
$524B
|
DK
David Koning
| $579.18 | $575 |
1%
downside
| Outperform |
16 Oct ‘24
10 months ago |
|
627
W.W. Grainger
GWW
$47.3B
|
DM
David Manthey
| $988.07 | $1,230 |
24%
upside
| Outperform |
16 Oct ‘24
10 months ago |
|
628
V2X
VVX
$1.73B
|
PA
Peter Arment
| $54.97 | $75 |
36%
upside
| Outperform |
11 Oct ‘24
11 months ago |
|
629
Amgen
AMGN
$150B
|
BS
Brian Skorney
| $278.57 | $215 |
23%
downside
| Underperform |
25 Sep ‘24
11 months ago |
|
630
FedEx
FDX
$53.3B
|
GH
Garrett Holland
| $225.85 | $320 |
42%
upside
| Outperform |
20 Sep ‘24
11 months ago |
|
631
Instil Bio
TIL
$158M
|
JA
Jack Allen
| $23.41 | $180 |
669%
upside
| Outperform |
16 Sep ‘24
11 months ago |
|
632
Sportsman's Warehouse
SPWH
$110M
|
PB
Peter Benedict
| $2.85 | $2.50 |
12%
downside
| Neutral |
4 Sep ‘24
1 year ago |
|
633
LivaNova
LIVN
$3.1B
|
MP
Mike Polark
| $56.83 | $55 |
3%
downside
| Neutral |
28 Aug ‘24
1 year ago |
|
634
Dick's Sporting Goods
DKS
$18.2B
|
JK
Justin Kleber
| $227.37 | $235 |
3%
upside
| Neutral |
28 Aug ‘24
1 year ago |
|
635
Williams-Sonoma
WSM
$24.5B
|
PB
Peter Benedict
| $201.40 | $140 |
30%
downside
| Neutral |
23 Aug ‘24
1 year ago |
|
636
Mersana Therapeutics
MRSN
$36.8M
|
CK
Colleen Kusy
| $7.38 | $75 |
916%
upside
| Neutral |
14 Aug ‘24
1 year ago |
|
637
Watts Water Technologies
WTS
$9.26B
|
MH
Michael Halloran
| $277.51 | $199 |
28%
downside
| Neutral |
9 Aug ‘24
1 year ago |
|
638
Savers
SVV
$1.96B
|
MA
Mark Altschwager
| $12.60 | $13 |
3%
upside
| Outperform |
9 Aug ‘24
1 year ago |
|
639
Ocular Therapeutix
OCUL
$2.23B
|
CK
Colleen Kusy
| $12.82 | $17 |
33%
upside
| Outperform |
8 Aug ‘24
1 year ago |
|
640
Definitive Healthcare
DH
$416M
|
VK
Vikram Kesavabhotla
| $4 | $5 |
25%
upside
| Neutral |
7 Aug ‘24
1 year ago |
|
641
BlackLine
BL
$3.35B
|
RO
Rob Oliver
| $54.09 | $65 |
20%
upside
| Outperform |
7 Aug ‘24
1 year ago |
|
642
Karyopharm Therapeutics
KPTI
$55.2M
|
MC
Mitch Collett
| $6.37 | $75 |
1,077%
upside
| Outperform |
7 Aug ‘24
1 year ago |
|
643
The RealReal
REAL
$1.04B
|
MA
Mark Altschwager
| $9.01 | $3.50 |
61%
downside
| Neutral |
7 Aug ‘24
1 year ago |
|
644
Realty Income
O
$54.4B
|
WG
Wesley Golladay
| $59.49 | $58 |
3%
downside
| Neutral |
6 Aug ‘24
1 year ago |
|
645
TELUS International
TIXT
$1.26B
|
DK
David Koning
| $4.51 | $4 |
11%
downside
| Neutral |
5 Aug ‘24
1 year ago |
|
646
Host Hotels & Resorts
HST
$12.1B
|
MB
Michael Bellisario
| $17.55 | $19 |
8%
upside
| Neutral |
5 Aug ‘24
1 year ago |
|
647
Sprout Social
SPT
$825M
|
RO
Rob Oliver
| $14.02 | $40 |
185%
upside
| Neutral |
2 Aug ‘24
1 year ago |
|
648
Schneider National
SNDR
$4.18B
|
BH
Benjamin Hartford
| $23.86 | $30 |
26%
upside
| Outperform |
2 Aug ‘24
1 year ago |
|
649
Axalta
AXTA
$6.71B
|
GP
Ghansham Panjabi
| $30.98 | $42 |
36%
upside
| Outperform |
2 Aug ‘24
1 year ago |
|
650
Neurocrine Biosciences
NBIX
$14.1B
|
BS
Brian Skorney
| $141.90 | $180 |
27%
upside
| Outperform |
2 Aug ‘24
1 year ago |
|